Eli Lilly just laid off the CEO and all the local staff of the Silicon Valley skin drug company it bought last year. Here's why.

It turns out the pharmaceutical giant wanted something other than the main drug Dermira made.

Source: bizjournals.com Health Care:Biotechnology headlines - April 13, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news